TurboVax Email Formats
Pharmaceutical Manufacturing • • 1-10 Employees
Key Contact at TurboVax
Kishore Alugupalli
Founder, Chairman, CEO
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 3254 |
| Employees | 1-10 |
About TurboVax
TurboVax Inc. was founded on June 26, 2023, by Dr. Kishore R. Alugupalli, PhD, Associate professor of Microbiology, and Immunology, Thomas Jefferson University, Philadelphia, PA, USA. Dr. Alugupalli currently is the fulltime CEO of TurboVax Inc, and is interested in commercialization of a ground-breaking vaccine adjuvant named Turbo. The major goal of TurboVax Inc is to partner with vaccine manufacturing or vaccine developing companies and organizations. The incorporation of Turbo as an adjuvant will significantly improve the immunogenicity and efficacy of polysaccharide subunit vaccines and help prevent bacterial infections globally.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
TurboVax has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
TurboVax has never raised funding before.
TurboVax Tech Stack
Discover the technologies and tools that power TurboVax's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Performance
Australia
Mauritius
Canada
United KingdomFrequently asked questions
4.8
40,000 users
